Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.
Read Full NewsTrial data showed that treatment with lamotrigine reduced myotonia severity in adults with genetically confirmed non-dystrophic myotonias, with sustained benefit and an acceptable safety profile.
The neurologist in the Department of Neurology at Saratoga Hospital Medical Group shared what excites her most about the future of neurology, specifically for movement disorders, in 2026.
COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD
FDA Accepts NDA for Priority Review of Centanafadine to Treat Adult, Pediatric ADHD
FDA Approves Labeling Update for iDose TR for Open-Angle Glaucoma and Ocular Hypertension
Apecotrep Delivers 40% Proteinuria Reduction in Phase 2 FSGS Trial
FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates
1.
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis
2.
Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.
3.
Combination therapy improves outcomes for advanced triple-negative breast cancer
4.
TULSA Is Effective in Long-Term Prostate Cancer Control.
5.
An individual state lost $4.02 billion due to untreated mental illness.
1.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
2.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
3.
Understanding Granulosa Cell Tumors: Symptoms, Diagnosis, and Treatments"
4.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
5.
The Cutting-Edge of Phlebectomy: Redefining Vein Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge